LY2409021

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for LY2409021, covering 2012-05-25 to 2019-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2409021 Formulations and the Effect of Food [Phase 1]